A spotlight on cancer researchers in Spain: new paradigms and disruptive ideas

Over the last years, there have been relevant advances in cancer research and in treatment based on specifc genetic alterations improving survival in some tumors. Nevertheless, progress is still dismal in most carcinomas when are disseminated with metastasis; the survival is less than 30% in most cases. Then, we need to move forward looking for new paradigms which may explain the complex mechanisms involved in carcinogenesis and in new treatment approaches.